Feedback / Questions
MACO-355 - Macomics
https://www.globenewswire.com/news-release/2024/04/11/2861274/0/en/Macomics-Unveils-its-Lead-First-in-Class-Anti-Pan-LILRB-Monoclonal-Antibody-Programme-with-Positive-Pre-clinical-Data-Presented-at-AACR-2024.html
Apr 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next